SI0989851T1 - Samoemulgirajoče formulacije za kisle lipofilne spojine - Google Patents
Samoemulgirajoče formulacije za kisle lipofilne spojineInfo
- Publication number
- SI0989851T1 SI0989851T1 SI9830303T SI9830303T SI0989851T1 SI 0989851 T1 SI0989851 T1 SI 0989851T1 SI 9830303 T SI9830303 T SI 9830303T SI 9830303 T SI9830303 T SI 9830303T SI 0989851 T1 SI0989851 T1 SI 0989851T1
- Authority
- SI
- Slovenia
- Prior art keywords
- self
- pharmaceutically acceptable
- emulsifying formulation
- composition
- lipophilic compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5401297P | 1997-07-29 | 1997-07-29 | |
PCT/US1998/014817 WO1999006044A1 (en) | 1997-07-29 | 1998-07-27 | Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
EP98936888A EP0989851B1 (en) | 1997-07-29 | 1998-07-27 | Self-emulsifying formulation for acidic lipophilic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0989851T1 true SI0989851T1 (sl) | 2003-04-30 |
Family
ID=21988155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9830303T SI0989851T1 (sl) | 1997-07-29 | 1998-07-27 | Samoemulgirajoče formulacije za kisle lipofilne spojine |
Country Status (25)
Country | Link |
---|---|
US (1) | US6231887B1 (sl) |
EP (1) | EP0989851B1 (sl) |
JP (1) | JP4524367B2 (sl) |
KR (1) | KR100509131B1 (sl) |
CN (1) | CN1112927C (sl) |
AT (1) | ATE225174T1 (sl) |
AU (1) | AU728626B2 (sl) |
BR (1) | BR9810729B1 (sl) |
CA (1) | CA2294033C (sl) |
CY (1) | CY2006002I2 (sl) |
CZ (1) | CZ296957B6 (sl) |
DE (1) | DE69808463T2 (sl) |
DK (1) | DK0989851T3 (sl) |
ES (1) | ES2184310T3 (sl) |
FI (1) | FI20000172A (sl) |
HK (1) | HK1028879A1 (sl) |
HU (1) | HU228923B1 (sl) |
NO (1) | NO323425B1 (sl) |
NZ (1) | NZ502566A (sl) |
PL (1) | PL192865B1 (sl) |
PT (1) | PT989851E (sl) |
RU (1) | RU2202346C2 (sl) |
SI (1) | SI0989851T1 (sl) |
SK (1) | SK284616B6 (sl) |
WO (1) | WO1999006044A1 (sl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6956048B2 (en) | 1999-03-31 | 2005-10-18 | Pharmacia & Upjohn Company | Pharmaceutical emulsions for retroviral protease inhibitors |
EP1165091B1 (en) * | 1999-03-31 | 2005-01-26 | PHARMACIA & UPJOHN COMPANY | Pharmaceutical emulsions for retroviral protease inhibitors |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
DK1333810T3 (da) * | 2000-10-31 | 2008-02-04 | Boehringer Ingelheim Pharma | Orale selvemulgerende doseringsformuleringer af pyranon-protease-inhibitorer |
SE0102993D0 (sv) * | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
US20030165545A1 (en) * | 2002-01-30 | 2003-09-04 | Allergan, Inc. | Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same |
BR0307344A (pt) * | 2002-02-01 | 2004-12-14 | Pfizer Prod Inc | Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica |
US6828301B2 (en) | 2002-02-07 | 2004-12-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for hepatitis C viral protease inhibitors |
US20040191332A1 (en) * | 2003-03-27 | 2004-09-30 | Allergan, Inc. | Preserved ophthalmic compositions |
WO2004093915A1 (en) * | 2003-04-02 | 2004-11-04 | Boehringer Ingelheim International, Gmbh | Pharmaceutical compositions for hepatitis c viral protease inhibitors |
EP1653927B1 (en) | 2003-08-04 | 2012-01-11 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
US7943670B2 (en) * | 2003-10-07 | 2011-05-17 | Eli Lilly And Company | Liquid formulations of ractopamine |
CA2583195A1 (en) * | 2004-11-19 | 2006-05-26 | Boehringer Ingelheim International Gmbh | Method for treating hiv infection through co-administration of tipranavir and reverset |
EP1814549A2 (en) * | 2004-11-19 | 2007-08-08 | Boehringer Ingelheim International GmbH | Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
CA2586501A1 (en) * | 2004-12-01 | 2006-06-08 | Boehringer Ingelheim International Gmbh | Method for treating hiv infection through co-administration of tipranavir and gw695634 |
JP5028885B2 (ja) * | 2006-07-04 | 2012-09-19 | 大正製薬株式会社 | ユビデカレノン含有自己乳化組成物 |
JP5448854B2 (ja) | 2007-03-12 | 2014-03-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | オリゴマー−プロテアーゼ阻害剤複合体 |
EP2262538B1 (en) * | 2008-03-12 | 2014-12-10 | Nektar Therapeutics | Oligomer-amino acid conjugate |
WO2010144869A2 (en) | 2009-06-12 | 2010-12-16 | Nektar Therapeutics | Protease inhibitors |
MA33491B1 (fr) * | 2009-07-07 | 2012-08-01 | Boehringer Ingelheim Int | Composition pharmaceutique pour un inhibiteur de protease virale de l'hépatite c |
WO2011047259A1 (en) | 2009-10-16 | 2011-04-21 | Glaxosmithkline Llc | Compositions |
RU2419426C1 (ru) * | 2010-04-26 | 2011-05-27 | Всеволод Иванович Киселев | Лекарственное средство на основе дииндолилметана (dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека |
BR112012028037A2 (pt) | 2010-05-03 | 2016-08-02 | Teikoku Pharma Usa Inc | formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
WO2014108569A1 (en) * | 2013-01-14 | 2014-07-17 | Biocopea Limited | Compositions and methods for treating severe pain |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4230702A (en) | 1978-01-09 | 1980-10-28 | Kali-Chemie Pharma Gmbh | Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents |
DE3300793A1 (de) * | 1983-01-12 | 1984-07-12 | Bayer Ag, 5090 Leverkusen | Coccidiosemittel |
GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5071643A (en) | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
IL102236A0 (en) * | 1991-06-27 | 1993-01-14 | Ltt Inst Co Ltd | Topical preparations containing cyclosporin |
GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
GB9208712D0 (en) * | 1992-04-22 | 1992-06-10 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporin derivates |
US5376688A (en) | 1992-12-18 | 1994-12-27 | R. P. Scherer Corporation | Enhanced solubility pharmaceutical solutions |
IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
CA2195623A1 (en) * | 1994-07-22 | 1996-02-08 | Rajeev D. Gokhale | Self-emulsifying drug delivery system |
AU692255B2 (en) * | 1995-04-24 | 1998-06-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Self-emulsifiable formulation producing an oil-in-water emulsion |
PL184820B1 (pl) | 1995-06-06 | 2002-12-31 | Hoffmann La Roche | Dawka jednostkowa kompozycji farmaceutycznej do leczenia chorób wywoływanych przez HIV |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
-
1998
- 1998-07-27 RU RU2000104861/14A patent/RU2202346C2/ru active
- 1998-07-27 NZ NZ502566A patent/NZ502566A/en not_active IP Right Cessation
- 1998-07-27 EP EP98936888A patent/EP0989851B1/en not_active Expired - Lifetime
- 1998-07-27 PL PL338335A patent/PL192865B1/pl unknown
- 1998-07-27 AU AU85738/98A patent/AU728626B2/en not_active Expired
- 1998-07-27 CA CA002294033A patent/CA2294033C/en not_active Expired - Lifetime
- 1998-07-27 HU HU0002440A patent/HU228923B1/hu unknown
- 1998-07-27 AT AT98936888T patent/ATE225174T1/de active
- 1998-07-27 SI SI9830303T patent/SI0989851T1/sl unknown
- 1998-07-27 CN CN98806771A patent/CN1112927C/zh not_active Expired - Lifetime
- 1998-07-27 KR KR10-2000-7000948A patent/KR100509131B1/ko not_active IP Right Cessation
- 1998-07-27 US US09/122,927 patent/US6231887B1/en not_active Expired - Lifetime
- 1998-07-27 BR BRPI9810729-1A patent/BR9810729B1/pt not_active IP Right Cessation
- 1998-07-27 DE DE69808463T patent/DE69808463T2/de not_active Expired - Lifetime
- 1998-07-27 SK SK16-2000A patent/SK284616B6/sk not_active IP Right Cessation
- 1998-07-27 ES ES98936888T patent/ES2184310T3/es not_active Expired - Lifetime
- 1998-07-27 PT PT98936888T patent/PT989851E/pt unknown
- 1998-07-27 JP JP51097399A patent/JP4524367B2/ja not_active Expired - Lifetime
- 1998-07-27 WO PCT/US1998/014817 patent/WO1999006044A1/en active IP Right Grant
- 1998-07-27 CZ CZ20000156A patent/CZ296957B6/cs not_active IP Right Cessation
- 1998-07-27 DK DK98936888T patent/DK0989851T3/da active
-
2000
- 2000-01-28 NO NO20000466A patent/NO323425B1/no not_active IP Right Cessation
- 2000-01-28 FI FI20000172A patent/FI20000172A/fi unknown
- 2000-12-21 HK HK00108284A patent/HK1028879A1/xx not_active IP Right Cessation
-
2006
- 2006-02-28 CY CY2006002C patent/CY2006002I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1028879A1 (en) | Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation | |
EP0882450A3 (en) | Cholesterol-lowering composition comprising coenzyme Q | |
HK1036931A1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients. | |
IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
PL338334A1 (en) | Pharmaceutic composition in the form of self-emulsifiable formulation of lipophilic compounds | |
IT1281337B1 (it) | Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla | |
CA2294031A1 (en) | SELF-EMULSIFYING FORMULATION FOR LIPOPHILIC COMPOUNDS | |
CA2414018A1 (en) | 2-aminocarbonyl-9h-purine derivatives | |
HUP0301972A2 (hu) | Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény | |
IL149163A0 (en) | Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
MY115016A (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
ES2189080T3 (es) | Derivados de creatina para el asma. | |
HUP0004701A2 (hu) | Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
PL308580A1 (en) | Solid pharmaceutical composition for oral administration and method of preparing same | |
HU9500175D0 (en) | Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives | |
SE0002354D0 (sv) | New formulation | |
YU82302A (sh) | Derivati 2-aminokarbonil-9h-purina | |
BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
IT1265045B1 (it) | Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a) |